MUSTAFA ATIK to Treatment Outcome
This is a "connection" page, showing publications MUSTAFA ATIK has written about Treatment Outcome.
Connection Strength
0.036
-
Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa. Breast Cancer Res Treat. 2006 May; 97(2):221.
Score: 0.021
-
Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014 Jan; 20(1):60-5.
Score: 0.009
-
Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer. Breast. 2005 Oct; 14(5):425.
Score: 0.005